Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunocore Holdings Plc ADR
(NQ:
IMCR
)
35.79
-1.11 (-3.01%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings Plc ADR
< Previous
1
2
3
4
5
Next >
Recap: Immunocore Hldgs Q1 Earnings
May 10, 2023
Via
Benzinga
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
May 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
April 18, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Analyst Ratings for Immunocore Hldgs
March 31, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Preview: Immunocore Holdings's Earnings
February 28, 2023
Via
Benzinga
Immunocore Reveals First Data From HIV Infection Candidate Study
February 22, 2023
Via
Benzinga
Short Volatility Alert: Immunocore Hldgs
April 17, 2023
On Friday, shares of Immunocore Hldgs (NASDAQ: IMCR) experienced volatile short activity. After the activity, the stock price went up +3.38% to $54.81. The overall sentiment for IMCR has been Bearish.
Via
Benzinga
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
Analyst Ratings for Immunocore Hldgs
November 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
Immunocore to present four posters at AACR Annual Meeting 2023
March 14, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports 2022 Financial Results and Provides Business Update
March 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
February 28, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
February 23, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
February 13, 2023
Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March.
Via
Investor's Business Daily
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Immunocore to present at upcoming investor conferences
February 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
3 Pharma Stocks That Will Mint Millionaires
January 30, 2023
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters.
Via
InvestorPlace
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
January 09, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via
Benzinga
Immunocore is awarded the Prix Galien France award for KIMMTRAK
December 15, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
December 08, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
December 02, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
November 30, 2022
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.